• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Fe3O4–Pd Janus nanoparticles with amplified dual-mode hyperthermia and enhanced ROS generation for breast cancer treatment?
  Yanyun Wang,Huijun Ma,Galong Li,Fei Gao,Mingli Peng,Hai Ming Fan Nanoscale Horiz., 2019,4, 1450-1459
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Primary amines

Introduction to Trans-Cyclopentane-1,2-Diamine (CAS No. 3145-88-8)

Trans-Cyclopentane-1,2-diamine, with the chemical formula C?H??N?, is a significant compound in the field of pharmaceutical chemistry and materials science. Its unique structural properties, characterized by a cyclopentane ring with two amino groups at the 1 and 2 positions in a trans configuration, make it a versatile intermediate in the synthesis of various bioactive molecules. This compound has garnered considerable attention due to its potential applications in drug development, particularly in the design of novel therapeutic agents targeting neurological and inflammatory disorders.

The molecular structure of trans-cyclopentane-1,2-diamine contributes to its remarkable reactivity and versatility. The presence of two amino groups allows for facile functionalization, enabling the synthesis of complex derivatives that exhibit diverse biological activities. Recent advancements in synthetic methodologies have further enhanced the accessibility of this compound, facilitating its incorporation into more sophisticated molecular architectures.

In the realm of pharmaceutical research, trans-cyclopentane-1,2-diamine has been explored as a key building block for the development of small-molecule drugs. Its structural motif is particularly relevant in the design of ligands for receptor binding studies. For instance, researchers have leveraged its framework to create analogs with potential applications in treating neurodegenerative diseases such as Alzheimer's and Parkinson's. The trans configuration of the amino groups imparts a specific spatial orientation that can be critical for receptor interaction, making this compound a valuable asset in medicinal chemistry.

Moreover, trans-cyclopentane-1,2-diamine has shown promise in materials science applications. Its ability to form stable coordination complexes with metal ions has led to investigations into its use as a chelating agent. These complexes exhibit interesting catalytic properties and have been explored in the development of novel catalysts for organic transformations. The compound's stability under various conditions further enhances its utility in industrial processes.

Recent studies have also highlighted the role of trans-cyclopentane-1,2-diamine in polymer chemistry. Its incorporation into polymer backbones results in materials with enhanced mechanical strength and biodegradability. Such polymers are particularly relevant in biomedical applications, where biodegradable scaffolds are essential for tissue engineering and drug delivery systems. The flexibility imparted by the cyclopentane ring allows for tailored material properties, making this compound an attractive candidate for advanced polymer design.

The synthesis of trans-cyclopentane-1,2-diamine has been refined through multiple pathways, each offering distinct advantages depending on the desired scale and purity requirements. One common approach involves the reduction of cyclopentanone derivatives using ammonia or ammonium salts under controlled conditions. Alternatively, cyclization reactions starting from linear precursors have also been reported to yield high yields of the desired product. These synthetic strategies underscore the compound's accessibility and readiness for industrial-scale production.

In conclusion, trans-cyclopentane-1,2-diamine (CAS No. 3145-88-8) is a multifaceted compound with broad applications across pharmaceuticals and materials science. Its unique structural features enable its use as a versatile intermediate in drug discovery and as a component in advanced materials. As research continues to uncover new possibilities for this compound, its significance is expected to grow further, solidifying its place as a cornerstone in modern chemical innovation.

• 175415-00-6(1,2-Cycloheptanediamine,(1S-trans)- (9CI))
• 115964-47-1(4,5-Nonanediamine)
• 77255-03-9((1S,2S)-cyclopentane-1,2-diamine)
• 477873-22-6((1S,2S)-Cyclopentane-1,2-diamine dihydrochloride)
• 632325-03-2(1,2-Cyclopentanediamine,conjugatemonoacid,(1R,2S)-rel-(9CI))
• 632325-08-7(1,2-Cyclopentanediamine,compd.)
• 41330-23-8(Cyclopentane-1,2-diamine)
• 632325-04-3(1,2-Cyclopentanediamine,conjugatemonoacid,(1R,2R)-rel-(9CI))
• 632325-05-4(1,2-Cyclopentanediamine,conjugatediacid,(1R,2S)-rel-(9CI))
• 632325-07-6(1,2-Cyclopentanediamine,conjugatediacid,(1R,2R)-rel-(9CI))